Aixial Group
↗Boulogne-Billancourt, France
Aixial Group is a global Contract Research Organization (CRO) and a subsidiary of the ALTEN Group. It provides comprehensive clinical development services, including full-service support, Functional Service Provision (FSP), and expert consulting, to pharmaceutical, biotechnology, and medical device companies.
The company specializes in managing clinical trials across all phases (I-IV), with particular expertise in oncology, cell & gene therapy, and rare diseases. Aixial Group integrates advanced technology, including AI-based solutions, to optimize clinical data management, biostatistics, and regulatory affairs, aiming to accelerate the delivery of innovative treatments to patients worldwide.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1001-5000
Founded:2004
Ownership:subsidiary
Status:operating
FUNDING
Investors:Naxicap Partners
PIPELINE
Modalities:Small molecule, Biologics, Cell therapy, Gene therapy, Medical devices
Active Trials:1580
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:ALTEN Group
Acquired By:ALTEN Group (2015-07-01)
Subsidiaries:Larix, Cmed Group
Key Partnerships:Medidata Solutions (Technology partner), Efrei Research Lab (AI and data science partnership)
COMPETITION
Position:Challenger
Competitors:Indegene, IntegriChain, Zuellig Pharma, Syneos Health, Parexel
LEADERSHIP
Key Executives:
Crista Casey - Chief Operations Officer
LINKS
Website:aixial.com
LinkedIn:LinkedIn Profile
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Aixial Group and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Aixial Group. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.